Skip to main content

Table 1 The prevalence and subtype distributions of Blastocystis among different groups

From: Prevalence and molecular subtyping of Blastocystis in patients with Clostridium difficile infection, Singapore

Groups

No. examined

No. positive

Prevalence (%) (95%)

OR (95%)

P value

Subtypes (n)

Group A

139

13

9.4% (4.5–14.2)

Reference

 

ST7 (9), ST3 (3), ST1 (1)

Group B

50

7

14% (4.4–23.6)

1.615 (0.605–4.3110)

0.363

ST7 (5), ST1 (2)

Group C

59

5

8.5% (1.4–15.6)

0.919 (0.312–2.703)

0.844

ST7 (2), ST1 (2), ST3 (1)

Total

248

25

10.1%

  

ST7 (16), ST1 (5), ST3 (4)

  1. Group A represents C. difficile antigen-negative patients; group B represents C. difficile antigen-positive and toxigenic-negative patients; group C represents both C. difficile antigen- and toxigenic-positive patients